Belarus has officially registered the revolutionary Cuban vaccine “CIMAvax”, which works by stimulating the immune system to destroy lung cancer cells, said Cuban Foreign Minister Bruno Rodriguez Parrilla.

“The first therapeutic vaccine against lung cancer, CIMAvax, received the sanitary registration in Belarus,” the minister said on social media on Sunday.

The Cuban pharmaceuticals industry continues to deliver great results despite restrictions stemming from the United States’ embargo, he added.

The CIMAvax vaccine, produced by the Cuban Center for Molecular Immunology, is the world’s first officially patented and registered vaccine against lung cancer.

Treatment with this vaccine allows a person’s immune system to produce neutralizing antibodies against epidermal growth factor (EGF).